Literature DB >> 24025276

Actinomycosis: an unusual cause of unresectable rectal cancer.

T Grey1, K Lindsay, A Bhowmick.   

Abstract

We present a very unusual case of a woman with an intrauterine contraceptive device (IUCD) who developed pelvic actinomycosis during long course chemoradiotherapy for rectal cancer, which presented a significant diagnostic challenge and eventually rendered the cancer unresectable. IUCDs are often implicated in the development of pelvic actinomycosis but there is no current evidence or guideline to suggest that they should be removed prior to oncological treatment. Owing to the devastating consequences of this combination of disease, we suggest that it may be prudent to remove IUCDs in this setting.

Entities:  

Mesh:

Year:  2013        PMID: 24025276      PMCID: PMC4188336          DOI: 10.1308/003588413X13629960047317

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  4 in total

Review 1.  Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature.

Authors:  Francisco Acevedo; Rene Baudrand; Luz M Letelier; Pablo Gaete
Journal:  Int J Infect Dis       Date:  2008-03-04       Impact factor: 3.623

Review 2.  Intrauterine device use among women with ovarian cancer: a systematic review.

Authors:  Lauren B Zapata; Maura K Whiteman; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2010-03-29       Impact factor: 3.375

3.  IUDs, inflammation, and infection: assessment after two decades of IUD use.

Authors:  W A Schmidt
Journal:  Hum Pathol       Date:  1982-10       Impact factor: 3.466

Review 4.  Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear.

Authors:  A S Fiorino
Journal:  Obstet Gynecol       Date:  1996-01       Impact factor: 7.661

  4 in total
  1 in total

1.  Microbiome characteristics and Bifidobacterium longum in colorectal cancer patients pre- and post-chemotherapy.

Authors:  Jun Li; Ruixue Chu; Changzheng Wang; Ying Li; Benyan Wu; Jun Wan
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.